ePCR - Ensemble Penalized Cox Regression for Survival Prediction
The top-performing ensemble-based Penalized Cox Regression
(ePCR) framework developed during the DREAM 9.5 mCRPC Prostate
Cancer Challenge
<https://www.synapse.org/ProstateCancerChallenge> presented in
Guinney J, Wang T, Laajala TD, et al. (2017)
<doi:10.1016/S1470-2045(16)30560-5> is provided here-in,
together with the corresponding follow-up work. While initially
aimed at modeling the most advanced stage of prostate cancer,
metastatic Castration-Resistant Prostate Cancer (mCRPC), the
modeling framework has subsequently been extended to cover also
the non-metastatic form of advanced prostate cancer (CRPC).
Readily fitted ensemble-based model S4-objects are provided,
and a simulated example dataset based on a real-life cohort is
provided from the Turku University Hospital, to illustrate the
use of the package. Functionality of the ePCR methodology
relies on constructing ensembles of strata in patient cohorts
and averaging over them, with each ensemble member consisting
of a highly optimized penalized/regularized Cox regression
model. Various cross-validation and other modeling schema are
provided for constructing novel model objects.